Ythdc2 Is an N6-Methyladenosine Binding Protein That Regulates Mammalian Spermatogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Identification of the Binding Partners for Hspb2 and Cryab Reveals
Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity. -
The Role of Cyclin B3 in Mammalian Meiosis
THE ROLE OF CYCLIN B3 IN MAMMALIAN MEIOSIS by Mehmet Erman Karasu A Dissertation Presented to the Faculty of the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy New York, NY November, 2018 Scott Keeney, PhD Date Dissertation Mentor Copyright © Mehmet Erman Karasu 2018 DEDICATION I would like to dedicate this thesis to my parents, Mukaddes and Mustafa Karasu. I have been so lucky to have their support and unconditional love in this life. ii ABSTRACT Cyclins and cyclin dependent kinases (CDKs) lie at the center of the regulation of the cell cycle. Cyclins as regulatory partners of CDKs control the switch-like cell cycle transitions that orchestrate orderly duplication and segregation of genomes. Similar to somatic cell division, temporal regulation of cyclin-CDK activity is also important in meiosis, which is the specialized cell division that generates gametes for sexual production by halving the genome. Meiosis does so by carrying out one round of DNA replication followed by two successive divisions without another intervening phase of DNA replication. In budding yeast, cyclin-CDK activity has been shown to have a crucial role in meiotic events such as formation of meiotic double-strand breaks that initiate homologous recombination. Mammalian cells express numerous cyclins and CDKs, but how these proteins control meiosis remains poorly understood. Cyclin B3 was previously identified as germ cell specific, and its restricted expression pattern at the beginning of meiosis made it an interesting candidate to regulate meiotic events. -
'Next- Generation' Sequencing Data Analysis
Novel Algorithm Development for ‘Next- Generation’ Sequencing Data Analysis Agne Antanaviciute Submitted in accordance with the requirements for the degree of Doctor of Philosophy University of Leeds School of Medicine Leeds Institute of Biomedical and Clinical Sciences 12/2017 ii The candidate confirms that the work submitted is her own, except where work which has formed part of jointly-authored publications has been included. The contribution of the candidate and the other authors to this work has been explicitly given within the thesis where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement ©2017 The University of Leeds and Agne Antanaviciute The right of Agne Antanaviciute to be identified as Author of this work has been asserted by her in accordance with the Copyright, Designs and Patents Act 1988. Acknowledgements I would like to thank all the people who have contributed to this work. First and foremost, my supervisors Dr Ian Carr, Professor David Bonthron and Dr Christopher Watson, who have provided guidance, support and motivation. I could not have asked for a better supervisory team. I would also like to thank my collaborators Dr Belinda Baquero and Professor Adrian Whitehouse for opening new, interesting research avenues. A special thanks to Dr Belinda Baquero for all the hard wet lab work without which at least half of this thesis would not exist. Thanks to everyone at the NGS Facility – Carolina Lascelles, Catherine Daley, Sally Harrison, Ummey Hany and Laura Crinnion – for the generation of NGS data used in this work and creating a supportive and stimulating work environment. -
Deep Multiomics Profiling of Brain Tumors Identifies Signaling Networks
ARTICLE https://doi.org/10.1038/s41467-019-11661-4 OPEN Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes Hong Wang 1,2,3, Alexander K. Diaz3,4, Timothy I. Shaw2,5, Yuxin Li1,2,4, Mingming Niu1,4, Ji-Hoon Cho2, Barbara S. Paugh4, Yang Zhang6, Jeffrey Sifford1,4, Bing Bai1,4,10, Zhiping Wu1,4, Haiyan Tan2, Suiping Zhou2, Laura D. Hover4, Heather S. Tillman 7, Abbas Shirinifard8, Suresh Thiagarajan9, Andras Sablauer 8, Vishwajeeth Pagala2, Anthony A. High2, Xusheng Wang 2, Chunliang Li 6, Suzanne J. Baker4 & Junmin Peng 1,2,4 1234567890():,; High throughput omics approaches provide an unprecedented opportunity for dissecting molecular mechanisms in cancer biology. Here we present deep profiling of whole proteome, phosphoproteome and transcriptome in two high-grade glioma (HGG) mouse models driven by mutated RTK oncogenes, PDGFRA and NTRK1, analyzing 13,860 proteins and 30,431 phosphosites by mass spectrometry. Systems biology approaches identify numerous master regulators, including 41 kinases and 23 transcription factors. Pathway activity computation and mouse survival indicate the NTRK1 mutation induces a higher activation of AKT down- stream targets including MYC and JUN, drives a positive feedback loop to up-regulate multiple other RTKs, and confers higher oncogenic potency than the PDGFRA mutation. A mini-gRNA library CRISPR-Cas9 validation screening shows 56% of tested master regulators are important for the viability of NTRK-driven HGG cells, including TFs (Myc and Jun) and metabolic kinases (AMPKa1 and AMPKa2), confirming the validity of the multiomics inte- grative approaches, and providing novel tumor vulnerabilities. -
Datasheet Blank Template
SAN TA C RUZ BI OTEC HNOL OG Y, INC . YTHDC2 (G-19): sc-249370 BACKGROUND APPLICATIONS YTHDC2 (YTH domain containing 2), also known as probable ATP-dependent YTHDC2 (G-19) is recommended for detection of YTHDC2 of mouse, rat and RNA helicase YTHDC2, is a 1,430 amino acid protein. Belonging to the DEAD human origin by Western Blotting (starting dilution 1:200, dilution range 1:100- box helicase family and DEAH subfamily, YTHDC2 contains two ANK repeats, 1:1000), immunofluorescence (starting dilution 1:50, dilution range 1:50-1:500) a helicase ATP-binding domain, helicase C-terminal domain, R3H domain and and solid phase ELISA (starting dilution 1:30, dilution range 1:30-1:3000); non a YTH domain, a potential RNA binding domain. The gene encoding YTHDC2 cross-reactive with YTHDC1. maps to human chromosome 5q22.2 and mouse chromosome 18 B3. With YTHDC2 (G-19) is also recommended for detection of YTHDC2 in additional 181 million base pairs encoding around 1,000 genes, chromosome 5 make up species, including bovine. approximately 6% of human genomic DNA. Chromosome 5 is associated with Cockayne syndrome through the ERCC8 gene and familial adenomatous poly - Suitable for use as control antibody for YTHDC2 siRNA (h): sc-91804, YTHDC2 posis through the adenomatous polyposis coli (APC) tumor suppressor gene. siRNA (m): sc-155422, YTHDC2 shRNA Plasmid (h): sc-91804-SH, YTHDC2 Treacher Collins syndrome is also chromosome 5 associated and is caused by shRNA Plasmid (m): sc-155422-SH, YTHDC2 shRNA (h) Lentiviral Particles: insertions or deletions within the TCOF1 gene. -
Ketu Mutant Mice Uncover an Essential Meiotic Function for the Ancient, Putative RNA Helicase YTHDC2
bioRxiv preprint doi: https://doi.org/10.1101/171827; this version posted August 6, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ketu mutant mice uncover an essential meiotic function for the ancient, putative RNA helicase YTHDC2 Devanshi Jain1, M. Rhyan Puno2,4, Kathryn V. Anderson3, and Scott Keeney1,4 * 1Molecular Biology Program, 2Structural Biology Program, 3Developmental Biology Program, and 4Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA Running title: Ythdc2 is essential for mouse meiosis Keywords Meiosis, spermatogonia, MEIOC, Bgcn, Bam, RNA binding proteins, gametogenesis *Correspondence: Scott Keeney Howard Hughes Medical Institute Molecular Biology Program Memorial Sloan Kettering Cancer Center 1275 York Ave, Box 97 New York, NY 10065 (212) 639-5182 [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/171827; this version posted August 6, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Mechanisms regulating mammalian meiotic progression are poorly understood. Here we identify mouse YTHDC2 as a critical component of this regulation. A screen yielded a mutant, “ketu”, with male and female sterility caused by a Ythdc2 missense mutation. Mutant germ cells enter meiosis but proceed prematurely to aberrant metaphase and apoptosis. -
Downregulation of M6a Reader YTHDC2 Promotes the Proliferation
Int. J. Biol. Sci. 2021, Vol. 17 2633 Ivyspring International Publisher International Journal of Biological Sciences 2021; 17(10): 2633-2651. doi: 10.7150/ijbs.58514 Research Paper Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway Jin Wang1#, Lirong Tan1#, Beibei Jia1, Xiaofan Yu1, Ruixin Yao1, Nan OUYang1, Xueting Yu1, Xiyuan Cao1, Jian Tong1, Tao Chen1, Rui Chen2 and Jianxiang Li1 1. Department of Toxicology, School of Public Health, Medicine College, Soochow University, Suzhou, Jiangsu, 215123, China. 2. Department of Respiratory Medicine, The Second Affiliated Hospital of Soochow University, Suzhou Jiangsu, 215004, China. #These authors contributed equally to this work. Corresponding authors: Jianxiang Li, E-mail: [email protected]; Rui Chen, E-mail: [email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2021.02.03; Accepted: 2021.06.08; Published: 2021.06.22 Abstract Lung cancer is one of the most common types of carcinoma worldwide. Cigarette smoking is considered the leading cause of lung cancer. Aberrant expression of several YT521-B homology (YTH) family proteins has been reported to be closely associated with multiple cancer types. The present study aims to evaluate the function and regulatory mechanisms of the N6-methyladenosine (m6A) reader protein YTH domain containing 2 (YTHDC2) by in vitro, in vivo and bioinformatics analyses. The results revealed that YTHDC2 was reduced in lung cancer and cigarette smoke-exposed cells. -
Datasheet Blank Template
SAN TA C RUZ BI OTEC HNOL OG Y, INC . Imp3 (AT32E9): sc-517409 BACKGROUND APPLICATIONS Imp3, also known as BRMS2, C15orf12 or MRPS4, is a 184 amino acid pro - Imp3 (AT32E9) is recommended for detection of Imp3 of human origin by tein that contains one S4 RNA-binding domain and is the mammalian homolog Western Blotting (starting dilution 1:200, dilution range 1:100-1:1000), of the yeast Imp3 protein. Localized to the nucleus, Imp3 exists as a compo - immunofluorescence (starting dilution 1:50, dilution range 1:50-1:500) and nent of a heterotrimeric complex consisting of MPP10, Imp3 and Imp4 and, in solid phase ELISA (starting dilution 1:30, dilution range 1:30-1:3000). this complex, plays a key role in early cleavage events during pre-18S ribo so - Suitable for use as control antibody for Imp3 siRNA (h): sc-89917, Imp3 mal processing. The gene encoding Imp3 maps to human chromosome 15, shRNA Plasmid (h): sc-89917-SH and Imp3 shRNA (h) Lentiviral Particles: which houses over 700 genes and comprises nearly 3% of the human genome. sc-89917-V. Angelman syndrome, Prader-Willi syndrome, Tay-Sachs disease and Marfan syndrome are all associated with defects in chromosome 15-localized genes. Molecular Weight of Imp3: 22 kDa. REFERENCES RECOMMENDED SUPPORT REAGENTS 1. Baserga, S.J., Agentis, T.M., Wormsley, S., Dunbar, D.A. and Lee, S. To ensure optimal results, the following support reagents are recommended: 1997. Mpp10p, a new protein component of the U3 snoRNP required for 1) Western Blotting: use m-IgG κ BP-HRP: sc-516102 or m-IgG κ BP-HRP processing of 18S rRNA precursors. -
Mechanisms Underlying Phenotypic Heterogeneity in Simplex Autism Spectrum Disorders
Mechanisms Underlying Phenotypic Heterogeneity in Simplex Autism Spectrum Disorders Andrew H. Chiang Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2021 © 2021 Andrew H. Chiang All Rights Reserved Abstract Mechanisms Underlying Phenotypic Heterogeneity in Simplex Autism Spectrum Disorders Andrew H. Chiang Autism spectrum disorders (ASD) are a group of related neurodevelopmental diseases displaying significant genetic and phenotypic heterogeneity. Despite recent progress in ASD genetics, the nature of phenotypic heterogeneity across probands is not well understood. Notably, likely gene- disrupting (LGD) de novo mutations affecting the same gene often result in substantially different ASD phenotypes. We find that truncating mutations in a gene can result in a range of relatively mild decreases (15-30%) in gene expression due to nonsense-mediated decay (NMD), and show that more severe autism phenotypes are associated with greater decreases in expression. We also find that each gene with recurrent ASD mutations can be described by a parameter, phenotype dosage sensitivity (PDS), which characteriZes the relationship between changes in a gene’s dosage and changes in a given phenotype. Using simple linear models, we show that changes in gene dosage account for a substantial fraction of phenotypic variability in ASD. We further observe that LGD mutations affecting the same exon frequently lead to strikingly similar phenotypes in unrelated ASD probands. These patterns are observed for two independent proband cohorts and multiple important ASD-associated phenotypes. The observed phenotypic similarities are likely mediated by similar changes in gene dosage and similar perturbations to the relative expression of splicing isoforms. -
Transcriptional Recapitulation and Subversion Of
Open Access Research2007KaiseretVolume al. 8, Issue 7, Article R131 Transcriptional recapitulation and subversion of embryonic colon comment development by mouse colon tumor models and human colon cancer Sergio Kaiser¤*, Young-Kyu Park¤†, Jeffrey L Franklin†, Richard B Halberg‡, Ming Yu§, Walter J Jessen*, Johannes Freudenberg*, Xiaodi Chen‡, Kevin Haigis¶, Anil G Jegga*, Sue Kong*, Bhuvaneswari Sakthivel*, Huan Xu*, Timothy Reichling¥, Mohammad Azhar#, Gregory P Boivin**, reviews Reade B Roberts§, Anika C Bissahoyo§, Fausto Gonzales††, Greg C Bloom††, Steven Eschrich††, Scott L Carter‡‡, Jeremy E Aronow*, John Kleimeyer*, Michael Kleimeyer*, Vivek Ramaswamy*, Stephen H Settle†, Braden Boone†, Shawn Levy†, Jonathan M Graff§§, Thomas Doetschman#, Joanna Groden¥, William F Dove‡, David W Threadgill§, Timothy J Yeatman††, reports Robert J Coffey Jr† and Bruce J Aronow* Addresses: *Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. †Departments of Medicine, and Cell and Developmental Biology, Vanderbilt University and Department of Veterans Affairs Medical Center, Nashville, TN 37232, USA. ‡McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706, USA. §Department of Genetics and Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. ¶Molecular Pathology Unit and Center for Cancer Research, Massachusetts deposited research General Hospital, Charlestown, MA 02129, USA. ¥Division of Human Cancer Genetics, The Ohio State University College of Medicine, Columbus, Ohio 43210-2207, USA. #Institute for Collaborative BioResearch, University of Arizona, Tucson, AZ 85721-0036, USA. **University of Cincinnati, Department of Pathology and Laboratory Medicine, Cincinnati, OH 45267, USA. ††H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. ‡‡Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, Massachusetts 02115, USA. -
35440 YTHDC2 Antibody
Revision 1 C 0 2 - t YTHDC2 Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] 0 Support: 877-678-TECH (8324) 4 4 Web: [email protected] 5 www.cellsignal.com 3 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB, IP H M R Mk Endogenous 160 Rabbit Q9H6S0 64848 Product Usage Information Application Dilution Western Blotting 1:1000 Immunoprecipitation 1:50 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity YTHDC2 Antibody recognizes endogenous levels of total YTHDC2 protein. Species Reactivity: Human, Mouse, Rat, Monkey Source / Purification Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly1243 of human YTHDC2 protein. Antibodies are purified by protein A and peptide affinity chromatography. Background YTH domain-containing protein 1 (YTHDC1) and YTH domain-containing protein 2 (YTHDC2) both belong to a family of proteins that bind to RNA. YTHDC1 and YTHDC2 both recognize and bind to N6-methyladenosine(m6A)-containing RNAs; binding is mediated through the YTH domains (1-3). m6A is a modification that is present at internal sites of mRNAs and some non-coding RNAs and plays a role in regulating mRNA splicing, processing, and stability. YTHDC1, also known as splicing factor YT521, regulates alternative splicing by functioning as a key regulator of exon-inclusion or exon- skipping. -
Inferring Biological Networks from Genome-Wide Transcriptional And
INFERRING BIOLOGICAL NETWORKS FROM GENOME-WIDE TRANSCRIPTIONAL AND FITNESS DATA By WAZEER MOHAMMAD VARSALLY A thesis submitted to The University of Birmingham for the degree of Doctor of Philosophy College of Life and Environmental Sciences School of Biosciences The University of Birmingham July 2013 I University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT In the last 15 years, the increased use of high throughput biology techniques such as genome-wide gene expression profiling, fitness profiling and protein interactomics has led to the generation of an extraordinary amount of data. The abundance of such diverse data has proven to be an essential foundation for understanding the complexities of molecular mechanisms and underlying pathways within a biological system. One approach of extrapolating biological information from this wealth of data has been through the use of reverse engineering methods to infer biological networks. This thesis demonstrates the capabilities and applications of such methodologies in identifying functionally enriched network modules in the yeast species Saccharomyces cerevisiae and Schizosaccharomyces pombe. This study marks the first time a mutual information based network inference approach has been applied to a set of specific genome-wide expression and fitness compendia, as well as the integration of these multi- level compendia.